Pineapple

Dosage for Pineapple allergenic extract is not measured in milligrams but in concentration and volume administered by a healthcare professional.

Skin Prick Testing (SPT)

• Standard Concentration: Usually provided as a 1:10 or 1:20 weight/volume (w/v) ratio in a glycerin base.
• Procedure: One drop (approximately 0.05 mL) is applied to the skin, and a sterile lancet is used to prick the skin through the drop.
• Observation: The site is observed for 15 to 20 minutes. A positive result is typically defined as a wheal (raised bump) that is 3mm larger than the negative control (saline).

Intradermal Testing

• Standard Concentration: If the prick test is negative, a more dilute solution (often 1:100 or 1:1000 w/v) may be used.
• Procedure: 0.02 mL to 0.05 mL is injected into the dermis (the layer of skin below the surface).

Pineapple allergenic extract is approved for use in pediatric populations, including infants, when a food allergy is suspected.

• Dosing: The procedure and concentration are identical to adult dosing. However, the number of tests performed at one time may be limited in small children to minimize discomfort and the risk of a systemic reaction.
• Interpretation: Healthcare providers must account for the fact that younger children may have smaller skin reactions compared to adults.

Renal Impairment

No dosage adjustments are required for patients with kidney disease, as the extract is administered topically/locally and does not undergo significant renal clearance.

Hepatic Impairment

No dosage adjustments are required for patients with liver disease.

Elderly Patients

Elderly patients may have reduced skin reactivity (reduced mast cell density or skin turgor). Healthcare providers may need to interpret results more cautiously, as false negatives are more common in patients over the age of 65.

Pineapple allergenic extract is never 'taken' by the patient at home. It must be administered in a clinical setting (doctor's office or hospital).

• Preparation: The skin (usually the forearm or back) is cleaned with alcohol and allowed to dry.
• Controls: A positive control (histamine) and a negative control (saline) must be administered simultaneously to ensure the test is valid.
• Timing: Patients must avoid antihistamines for at least 3 to 7 days before the test, as these medications will block the reaction and lead to a false negative.
• Storage: The extract must be stored in a refrigerator at 2°C to 8°C (36°F to 46°F). It should not be frozen.

Since this is a diagnostic test performed during a scheduled appointment, a 'missed dose' is simply a missed appointment. If the test is interrupted, it can be repeated at the discretion of the allergist, provided the patient has not developed a systemic reaction.

In the context of allergenic extracts, an 'overdose' refers to the administration of too much allergen or testing a patient who is extremely hypersensitive, leading to a systemic allergic reaction.

• Signs of Overdose (Systemic Reaction): Generalized itching, hives (urticaria), swelling of the throat, wheezing, shortness of breath, or a drop in blood pressure (anaphylaxis).
• Emergency Measures: If a systemic reaction occurs, the extract must be wiped off immediately. The primary treatment is the intramuscular injection of epinephrine (0.3 mg for adults, 0.15 mg for children). Oxygen, intravenous fluids, and antihistamines may also be administered.

> Important: Follow your healthcare provider's instructions regarding medication restrictions before the test. Do not attempt to use allergenic extracts outside of a medical facility.

Because the purpose of Pineapple allergenic extract is to elicit a local immune response, certain 'side effects' are actually expected outcomes of a positive test.

• Local Wheal and Flare: A raised, itchy bump (wheal) surrounded by a red area (flare) at the site of the test. This typically appears within 15 minutes and subsides within 1 to 2 hours.
• Pruritus (Itching): Intense itching at the test site is very common and is a direct result of histamine release.
• Local Erythema: Redness of the skin surrounding the prick site that may spread slightly beyond the initial drop area.

• Delayed Local Reaction: Some patients may experience swelling and redness at the test site several hours after the initial test has concluded. This is known as a late-phase reaction and is generally not dangerous.
• Persistent Itching: Itching that lasts for more than 24 hours at the site of administration.
• Small Blisters: In very sensitive individuals, a small vesicle or blister may form at the site of a strongly positive reaction.

• Lymphangitis: Inflammation of the lymphatic vessels leading away from the test site, appearing as a red streak.
• Skin Discoloration: Temporary darkening (hyperpigmentation) or lightening (hypopigmentation) of the skin at the test site, particularly in individuals with darker skin tones.
• Fainting (Vasovagal Syncope): Some patients may faint during the procedure due to anxiety or the pain of the skin prick, rather than a reaction to the pineapple extract itself.

> Warning: Stop the procedure and call for emergency medical help immediately if you experience any of the following systemic symptoms after the application of Pineapple extract.

• Anaphylaxis: A severe, life-threatening allergic reaction that can affect multiple organ systems. Symptoms include a rapid pulse, dizziness, and a feeling of 'impending doom.'
• Angioedema: Deep swelling under the skin, particularly around the lips, eyes, or tongue, which can obstruct the airway.
• Bronchospasm: Tightening of the muscles lining the airways, causing severe wheezing, chest tightness, and difficulty breathing.
• Hypotension: A sudden, dangerous drop in blood pressure that can lead to shock.
• Generalized Urticaria: Hives that spread to parts of the body far away from the initial test site.

There are no known long-term side effects associated with a single diagnostic use of Pineapple allergenic extract. Unlike immunotherapy (allergy shots), which involves repeated exposure over years, diagnostic testing is a one-time or infrequent event. There is a theoretical risk of 'sensitization' (developing an allergy because of the test), but this is extremely rare with skin prick testing.

While Pineapple allergenic extract itself may not always carry a specific black box warning, the class of Allergenic Extracts as a whole carries an FDA-mandated warning regarding the risk of severe systemic reactions.

Summary of Warning: Allergenic extracts can cause severe life-threatening systemic reactions, including anaphylaxis. Patients must be observed for at least 30 minutes following administration. These extracts should only be used by physicians who are exceptionally experienced in the treatment of anaphylaxis and have immediate access to emergency equipment, including epinephrine, oxygen, and airway management tools.

Report any unusual symptoms or delayed reactions to your healthcare provider immediately.

Pineapple allergenic extract is intended only for diagnostic use by healthcare professionals trained in allergy and immunology. It is not for self-administration. The most critical safety consideration is the potential for a systemic allergic reaction. Patients must remain in the clinical setting for a minimum of 30 minutes after the test is completed to ensure that any immediate hypersensitivity reactions can be treated promptly.

No specific FDA black box warning exists for Pineapple extract alone, but it falls under the general warning for all allergenic extracts:

• Risk of Anaphylaxis: This product can cause severe, systemic allergic reactions which may be fatal.
• Clinical Setting: Must be administered in a facility equipped to handle respiratory and cardiac arrest.
• Patient Selection: Use with extreme caution in patients with unstable asthma, as they are at higher risk for fatal reactions.

• Allergic Reactions / Anaphylaxis Risk: Patients with a history of severe reactions to pineapple or those with high levels of specific IgE are at increased risk. The allergist may choose to use a more dilute solution or skip skin testing in favor of a blood test (sIgE) if the risk is deemed too high.
• Asthma: Patients with poorly controlled or severe asthma are at a significantly higher risk for a severe systemic reaction during skin testing. The patient's asthma should be stable before testing proceeds.
• Beta-Blocker Use: Patients taking beta-blockers (e.g., metoprolol, propranolol) may be resistant to the effects of epinephrine, which is the primary treatment for anaphylaxis. This makes any potential reaction much harder to treat.
• Dermatographism: Some patients have skin that 'writes' (welts easily from a simple scratch). This can lead to false-positive results with Pineapple extract.

• Post-Test Observation: Vital signs (blood pressure, heart rate) and respiratory status should be monitored if the patient shows any signs of distress.
• Skin Inspection: The test site must be measured accurately using a millimeter ruler to distinguish between a positive reaction and a negative one.
• Lab Tests: Before skin testing, a physician may order a Total IgE or a Specific IgE blood test (ImmunoCAP) to gauge the patient's level of sensitivity.

Under normal circumstances, Pineapple allergenic extract does not affect the ability to drive or operate machinery. However, if a patient experiences a vasovagal reaction (fainting) or a systemic reaction requiring medication (like diphenhydramine, which causes drowsiness), they should not drive until they are fully recovered.

Alcohol consumption does not directly interact with Pineapple extract, but alcohol can increase skin blood flow and potentially exacerbate the itching or redness of a positive test. It is generally advised to avoid alcohol on the day of testing.

As this is a one-time diagnostic test, there is no tapering or withdrawal syndrome. If a patient experiences a severe reaction, the test is discontinued immediately, and the substance is removed from the skin.

> Important: Discuss all your medical conditions, especially respiratory issues and current medications, with your healthcare provider before undergoing allergy testing with Pineapple extract.

There are no drugs that are strictly 'contraindicated' in the sense of causing a toxic chemical reaction, but certain drugs make the test dangerous or impossible to interpret:

• Beta-Blockers (e.g., Atenolol, Carvedilol): These drugs can block the effects of epinephrine. If the Pineapple extract causes anaphylaxis, the life-saving treatment (epinephrine) may not work effectively. Many allergists will not perform skin testing until the patient has safely transitioned off beta-blockers under a doctor's supervision.

• ACE Inhibitors (e.g., Lisinopril, Enalapril): Similar to beta-blockers, ACE inhibitors may increase the severity of an allergic reaction and complicate the treatment of anaphylaxis.
• MAO Inhibitors (e.g., Phenelzine): These can interfere with the metabolism of epinephrine, potentially leading to a hypertensive crisis if epinephrine must be administered for a reaction to the extract.

• Antihistamines (e.g., Loratadine, Cetirizine, Diphenhydramine): These drugs are the most common cause of 'false negative' results. They block the H1 receptors in the skin, preventing the wheal and flare reaction even if the patient is allergic. Patients must typically stop these 3 to 7 days before testing.
• Tricyclic Antidepressants (e.g., Amitriptyline): These have potent antihistamine properties and can suppress skin test reactions for up to two weeks.
• H2 Blockers (e.g., Famotidine, Ranitidine): While less potent than H1 blockers, they can also partially suppress the skin's response to the Pineapple allergen.

• Cross-Reactive Foods: If a patient has recently consumed large amounts of pineapple, it may theoretically affect the skin's reactivity, though this is not clinically standardized.
• Latex-Fruit Syndrome: Patients allergic to latex, bananas, avocados, or chestnuts may show a positive reaction to Pineapple extract due to cross-reactivity between chitinases and other proteins.

• High-Dose Vitamin C: Some studies suggest Vitamin C has mild antihistamine properties, which could theoretically dampen a skin test reaction.
• Quercetin: This supplement is often used as a natural mast cell stabilizer and may interfere with the accuracy of the Pineapple allergy test.

• Skin Testing vs. Blood Testing: The administration of a skin test can occasionally cause a transient rise in the levels of Pineapple-specific IgE in the blood if measured shortly after the skin test (a 'booster' effect).

For each major interaction, the mechanism is usually pharmacodynamic (affecting the body's response to the allergen or the treatment for a reaction) rather than pharmacokinetic (affecting the drug's metabolism).

> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, especially those for blood pressure, depression, or allergies.

Pineapple allergenic extract must NEVER be used in the following circumstances:

• History of Severe Anaphylaxis to Pineapple: If a patient has already had a life-threatening reaction to eating pineapple, skin testing is often considered too risky and unnecessary for diagnosis.
• Unstable or Severe Asthma: Patients with an FEV1 (Forced Expiratory Volume) of less than 70% of predicted, or those with frequent exacerbations, are at high risk for a fatal reaction if a systemic response occurs.
• Acute Systemic Illness: Testing should not be performed if the patient is currently experiencing a fever, infection, or an acute allergic flare-up (e.g., active hives).

Conditions requiring a careful risk-benefit analysis include:

• Pregnancy: While not strictly forbidden, most allergists avoid skin testing during pregnancy due to the risk of anaphylaxis, which can cause fetal hypoxia (lack of oxygen).
• Severe Atopic Dermatitis (Eczema): If the skin is extensively inflamed or infected, there may not be enough 'clear' skin to perform an accurate test.
• Dermatographism: As mentioned, this condition causes the skin to welt from the pressure of the lancet alone, making the Pineapple test result impossible to read.
• Beta-Blocker Therapy: If the patient cannot safely stop their beta-blocker, the allergist may opt for a blood test (In Vitro testing) instead of a skin test.

Patients should be evaluated for cross-sensitivity to the following substances before Pineapple testing:

• Natural Rubber Latex: High rates of cross-reactivity exist.
• Bromelain Supplements: Patients who have reacted to digestive enzymes containing bromelain are likely to react to Pineapple extract.
• Other Bromeliads: Sensitivity to other plants in the Bromeliaceae family.

> Important: Your healthcare provider will evaluate your complete medical history, including your lung function and current medications, before deciding if a Pineapple skin test is safe for you.

FDA Pregnancy Category: Not Formally Assigned (Typically treated as Category C).

There are no adequate and well-controlled studies of Pineapple allergenic extract in pregnant women. The primary concern is not the extract itself, but the potential for a systemic allergic reaction (anaphylaxis). Anaphylaxis in a pregnant woman can lead to uterine contractions, placental abruption, and fetal distress due to oxygen deprivation. Therefore, diagnostic skin testing with Pineapple extract is generally deferred until after delivery unless the information is critical for immediate management.

It is not known whether the proteins in Pineapple allergenic extract are excreted in human milk. However, since the amount used in skin testing is microscopic and localized, it is highly unlikely to affect a nursing infant. The main risk remains a systemic reaction in the mother, which could temporarily interfere with breastfeeding. Healthcare providers generally consider skin testing safe for breastfeeding mothers.

Pineapple extract is safe and effective for use in children to diagnose food allergies.

• Age Considerations: Testing can be performed at any age, including in infants. However, infants under 6 months old may have smaller skin reactions, leading to potential false negatives.
• Growth Effects: There are no known effects on growth or development from diagnostic testing.
• Special Dosing: The volume of the extract is the same as in adults, but the number of simultaneous tests may be reduced to prevent 'overwhelming' the child's immune system or causing excessive distress.

In patients over 65, the skin's reactivity to histamine and allergens tends to decrease.

• Pharmacokinetic Changes: Reduced skin turgor and capillary density can lead to smaller wheal sizes.
• Polypharmacy: Elderly patients are more likely to be on beta-blockers or ACE inhibitors, increasing the risks associated with testing.
• Interpretation: A negative skin test in an elderly patient may need to be confirmed with a blood test if clinical suspicion of pineapple allergy is high.

No adjustments are needed for patients with renal impairment. The allergenic proteins are not cleared by the kidneys in significant quantities following a skin prick test.

No adjustments are needed for patients with hepatic impairment. The liver does not play a role in the local immune response or the breakdown of the small amount of protein used in the diagnostic procedure.

> Important: Special populations, particularly pregnant women and the elderly, require a personalized assessment by an allergist to balance the need for diagnosis against the risks of testing.

Pineapple allergenic extract functions as a diagnostic biological agent. Its molecular mechanism involves the cross-linking of IgE antibodies bound to the high-affinity IgE receptor (FcεRI) on the surface of mast cells and basophils.

1. 1Binding: The major allergens in the extract, such as Ana c 1 (a 25 kDa thiol protease) and Ana c 2 (bromelain), are recognized by the Fab portion of specific IgE antibodies.
2. 2Degranulation: When two or more IgE receptors are cross-linked by the pineapple proteins, a signal transduction cascade is initiated within the mast cell.
3. 3Mediator Release: This results in the 'exocytosis' (release) of pre-formed mediators like histamine and the rapid synthesis of newly formed mediators like leukotrienes.
4. 4Physiological Response: These mediators act on H1 receptors in the local vasculature, causing the 'wheal' (edema) and 'flare' (vasodilation) that constitutes a positive test.

• Dose-Response: There is a direct correlation between the concentration of the extract and the size of the wheal, up to a plateau point.
• Time to Onset: The reaction begins within seconds, with the peak wheal size occurring between 15 and 20 minutes.
• Duration: The immediate reaction fades within 1-2 hours, though a late-phase reaction involving eosinophil recruitment can occur 4-8 hours later.

| Parameter | Value |

|---|---|

| Bioavailability | Local: High; Systemic: Minimal |

| Protein Binding | N/A (Binds to IgE on cells) |

| Half-life (Local) | ~30-60 minutes |

| Tmax (Reaction) | 15-20 minutes |

| Metabolism | Local Proteolysis |

| Excretion | Lymphatic clearance |

• Composition: A complex mixture of proteins, glycoproteins, and polysaccharides extracted from Ananas comosus.
• Major Allergens: Ana c 1 (Bromelain), Ana c 2 (Thiol protease), and Profilin (Ana c 3).
• Solubility: Soluble in aqueous solutions and glycerin-based buffers.
• Molecular Weight: Ranges from 10 kDa to over 50 kDa for various protein fractions.

Pineapple extract is a Non-Standardized Food Allergenic Extract. It is grouped with other plant-derived extracts used in the diagnosis of Type I hypersensitivity. It is distinct from 'standardized' extracts (like grass pollens or dust mites) because it does not have a federally mandated bioequivalent unit (like BAU/mL).